Butane

Butane

SCHEMBL6828567

CC(C)CCOC(=O)CC(=O)O.CCCC

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.42
MAPK1 P28482 2/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PKM P14618 2/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 2/20 0.37
SLC22A1 O15245 1/20 0.37
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA4 P43681 2/20 0.37
EPHX2 P34913 1/20 0.37
FAAH O00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635716 0.94 CYP19A1 (0.46) CYP19A1MAPK1CA12CA1CA2
Butane SCHEMBL6048873 0.90 GAA (0.46) CYP19A1MAPK1CA12CA1CA2
SCHEMBL2267201 0.83 CYP19A1 (0.50) CYP19A1MAPK1CA12CA1CA2
Butane SCHEMBL19690452 0.83 CYP19A1 (0.41) CYP19A1MAPK1CA12CA1CA2
SCHEMBL4487325 0.81 PKM (0.39) CYP19A1MAPK1CA12CA1CA2
Butane SCHEMBL452621 0.81 GAA (0.44) GAAMGAMSIMGAM2FAAH
SCHEMBL6322410 0.80 BLM (0.50) CYP19A1KMT2A
Butane SCHEMBL5526854 0.80 TSHR (0.41) TDP1GAAMGAMSIMGAM2
SCHEMBL28099367 0.79 CYP19A1 (0.47) CYP19A1MAPK1CA12CA1CA2
SCHEMBL11254147 0.79 KDM4C (0.44) CYP19A1FAAHALDH1A1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004076425-A1 IMPROVED SYNTHESIS OF MACROCYCLIC TETRAAMIDO COMPOUNDS AND NEW METAL INSERTION PROCESS CARNEGIE MELLON UNIVERSITY (US) 2004-09-10 WO disclosed